AI
ZBH icon

AXS Investments’s Zimmer Biomet ZBH Stock Holding History

AXS Investments’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-603
Closed -$73.4K – 432
2023
Q4 		$73.4K Sell
603
-40
-6% -$4.46K 0.02% 348
2023
Q3 		$72.2K Sell
643
-68
-10% -$8.63K 0.02% 324
2023
Q2 		$104K Sell
711
-22
-3% -$2.99K 0.03% 301
2023
Q1 		$94.7K Sell
733
-89
-11% -$11.2K 0.03% 262
2022
Q4 		$105K Buy
+822
New +$95.4K 0.04% 234
2022
Q1 		– Sell
-3,779
Closed -$466K – 185
2021
Q4 		$466K Buy
+3,779
New +$495K 0.11% 116
2021
Q3 		– Sell
-3,317
Closed -$518K – 223
2021
Q2 		$518K Buy
3,317
+699
+27% +$113K 0.16% 118
2021
Q1 		$407K Buy
+2,618
New +$406K 0.14% 117

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AXS Investments's ZBH Position: Q1 2024 in Review

AXS Investments sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 603 shares — an estimated $73.4K sold.

AXS Investments first reported a position in ZBH in Q1 2021 and held it in 8 quarters. The position peaked at $518K in Q2 2021. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

  • AXS Investments reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
  • AXS Investments sold 603 Zimmer Biomet shares in Q1 2024, an estimated $73.4K.
  • AXS Investments first reported a position in Zimmer Biomet in Q1 2021 and held it in 8 quarters.
  • AXS Investments's Zimmer Biomet position peaked at $518K in Q2 2021.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on AXS Investments's 13F filing for Q1 2024, filed 13 May 2024.